Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking

NCT06223828 is registered in ClinicalTrials.gov with Johns Hopkins All Children's Hospital as lead sponsor.

NCT NCT06223828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking
Lead sponsor
Johns Hopkins All Children's Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 2, 2024
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, pediatric asthma